Trial
NCT02212574
Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
The Matthew Larson Foundation for Pediatric Brain Tumors
Condition
Medulloblastoma
Intervention
Lomustine
Why stopped
Participant relapses led to abrupt stop of study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-05